Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Invasive Pleomorphic-Type Lobular Carcinoma of the Breast Presenting as a Mucinous Carcinoma.

Baig A, Omeroglu-Altinel G, Omeroglu A.

Case Rep Pathol. 2019 Aug 4;2019:1839208. doi: 10.1155/2019/1839208. eCollection 2019.

2.

Value of Shear Wave Elastography for the Differentiation of Benign and Malignant Microcalcifications of the Breast.

Chamming's F, Mesurolle B, Antonescu R, Aldis A, Kao E, Thériault M, Omeroglu A, Pinel-Giroux F, Seidler M, Solorzano S, Reinhold C, Gallix B.

AJR Am J Roentgenol. 2019 Aug;213(2):W85-W92. doi: 10.2214/AJR.18.20899. Epub 2019 Apr 30.

PMID:
31039014
3.

Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers.

Gruosso T, Gigoux M, Manem VSK, Bertos N, Zuo D, Perlitch I, Saleh SMI, Zhao H, Souleimanova M, Johnson RM, Monette A, Ramos VM, Hallett MT, Stagg J, Lapointe R, Omeroglu A, Meterissian S, Buisseret L, Van den Eynden G, Salgado R, Guiot MC, Haibe-Kains B, Park M.

J Clin Invest. 2019 Apr 1;129(4):1785-1800. doi: 10.1172/JCI96313. Epub 2019 Mar 18.

4.

Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer.

Li X, Gruosso T, Zuo D, Omeroglu A, Meterissian S, Guiot MC, Salazar A, Park M, Levine H.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3678-3687. doi: 10.1073/pnas.1817652116. Epub 2019 Feb 7.

5.

Afadin cooperates with Claudin-2 to promote breast cancer metastasis.

Tabariès S, McNulty A, Ouellet V, Annis MG, Dessureault M, Vinette M, Hachem Y, Lavoie B, Omeroglu A, Simon HG, Walsh LA, Kimbung S, Hedenfalk I, Siegel PM.

Genes Dev. 2019 Feb 1;33(3-4):180-193. doi: 10.1101/gad.319194.118. Epub 2019 Jan 28.

6.

Imaging features of pure and mixed forms of mucinous breast carcinoma with histopathological correlation.

Chaudhry AR, El Khoury M, Gotra A, Eslami Z, Omeroglu A, Omeroglu-Altinel G, Chaudhry SH, Mesurolle B.

Br J Radiol. 2019 Mar;92(1095):20180810. doi: 10.1259/bjr.20180810. Epub 2019 Jan 11.

PMID:
30632779
7.

Enhancement of breast cancer on pre-treatment dynamic contrast-enhanced MRI using computer-aided detection is associated with response to neo-adjuvant chemotherapy.

Chamming's F, Ueno Y, Aldis A, Seidler M, Mesurolle B, Omeroglu A, Gallix B, Reinhold C.

Diagn Interv Imaging. 2018 Dec;99(12):773-781. doi: 10.1016/j.diii.2018.09.001. Epub 2018 Oct 22.

8.

Evaluating the Impact of Breast Density on Preoperative MRI in Invasive Lobular Carcinoma.

Wong SM, Prakash I, Trabulsi N, Parsyan A, Moldoveanu D, Zhang D, Mesurolle B, Omeroglu A, Aldis A, Meterissian S.

J Am Coll Surg. 2018 May;226(5):925-932. doi: 10.1016/j.jamcollsurg.2018.01.045. Epub 2018 Feb 6.

PMID:
29421692
9.

A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer.

Savage P, Blanchet-Cohen A, Revil T, Badescu D, Saleh SMI, Wang YC, Zuo D, Liu L, Bertos NR, Munoz-Ramos V, Basik M, Petrecca K, Asselah J, Meterissian S, Guiot MC, Omeroglu A, Kleinman CL, Park M, Ragoussis J.

Cell Rep. 2017 Oct 31;21(5):1140-1149. doi: 10.1016/j.celrep.2017.10.015.

10.

Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.

Chamming's F, Ueno Y, Ferré R, Kao E, Jannot AS, Chong J, Omeroglu A, Mesurolle B, Reinhold C, Gallix B.

Radiology. 2018 Feb;286(2):412-420. doi: 10.1148/radiol.2017170143. Epub 2017 Oct 4.

PMID:
28980886
11.

Progressive polarity loss and luminal collapse disrupt tissue organization in carcinoma.

Halaoui R, Rejon C, Chatterjee SJ, Szymborski J, Meterissian S, Muller WJ, Omeroglu A, McCaffrey L.

Genes Dev. 2017 Aug 1;31(15):1573-1587. doi: 10.1101/gad.300566.117. Epub 2017 Sep 8.

12.

Immunohistochemistry Microarrays.

Li H, Brewer G, Ongo G, Normandeau F, Omeroglu A, Juncker D.

Anal Chem. 2017 Sep 5;89(17):8620-8625. doi: 10.1021/acs.analchem.7b00807. Epub 2017 Aug 23.

PMID:
28763195
13.

Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer.

Saleh SMI, Bertos N, Gruosso T, Gigoux M, Souleimanova M, Zhao H, Omeroglu A, Hallett MT, Park M.

Cancer Res. 2017 Sep 1;77(17):4673-4683. doi: 10.1158/0008-5472.CAN-16-3427. Epub 2017 Jun 26.

14.

Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.

Chamming's F, Kao E, Aldis A, Ferré R, Omeroglu A, Reinhold C, Mesurolle B.

Br J Radiol. 2017 May;90(1073):20170128. doi: 10.1259/bjr.20170128. Epub 2017 Apr 3.

15.

Sonographic Appearance of Lesions Diagnosed as Lobular Neoplasia at Sonographically Guided Biopsies.

Ferré R, Omeroglu A, Mesurolle B.

AJR Am J Roentgenol. 2017 Mar;208(3):669-675. doi: 10.2214/AJR.15.15056. Epub 2017 Jan 11.

PMID:
28075608
16.

Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.

Marcil G, Wong S, Trabulsi N, Allard-Coutu A, Parsyan A, Omeroglu A, Atinel G, Mesurolle B, Meterissian S.

Am J Surg. 2017 Aug;214(2):318-322. doi: 10.1016/j.amjsurg.2016.12.017. Epub 2016 Dec 27.

PMID:
28057293
17.

Who can get the next Nobel Prize in infectious diseases?

Ergonul O, Yalcin CE, Erkent MA, Demirci M, Uysal SP, Ay NZ, Omeroglu A.

Int J Infect Dis. 2016 Apr;45:88-91. doi: 10.1016/j.ijid.2016.02.022. Epub 2016 Mar 2.

18.

Imaging Features Associated With Posttraumatic Breast Neuromas.

AlSharif S, Ferré R, Omeroglu A, El Khoury M, Mesurolle B.

AJR Am J Roentgenol. 2016 Mar;206(3):660-5. doi: 10.2214/AJR.14.14035.

PMID:
26901025
19.

Differentiation of Fibroadenomas and Pure Mucinous Carcinomas on Dynamic Contrast-Enhanced MRI of the Breast Using Volume Segmentation for Kinetic Analysis: A Feasibility Study.

Ferré R, Aldis A, AlSharif S, Omeroglu A, Mesurolle B.

AJR Am J Roentgenol. 2016 Feb;206(2):253-8. doi: 10.2214/AJR.15.14709.

PMID:
26797351
20.

Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.

Proulx F, Correa JA, Ferré R, Omeroglu A, Aldis A, Meterissian S, Mesurolle B.

Br J Radiol. 2016;89(1058):20150543. doi: 10.1259/bjr.20150543. Epub 2015 Nov 16.

21.

Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.

Smith AL, Alirezaie N, Connor A, Chan-Seng-Yue M, Grant R, Selander I, Bascuñana C, Borgida A, Hall A, Whelan T, Holter S, McPherson T, Cleary S, Petersen GM, Omeroglu A, Saloustros E, McPherson J, Stein LD, Foulkes WD, Majewski J, Gallinger S, Zogopoulos G.

Cancer Lett. 2016 Jan 28;370(2):302-12. doi: 10.1016/j.canlet.2015.10.030. Epub 2015 Nov 3.

22.

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.

Dupuy F, Tabariès S, Andrzejewski S, Dong Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, Clemons M, Aguilar-Mahecha A, Basik M, Vincent EE, St-Pierre J, Jones RG, Siegel PM.

Cell Metab. 2015 Oct 6;22(4):577-89. doi: 10.1016/j.cmet.2015.08.007. Epub 2015 Sep 10.

23.

Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis.

Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C.

Onco Targets Ther. 2015 Apr 21;8:911-9. doi: 10.2147/OTT.S71089. eCollection 2015.

24.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G.

Curr Oncol. 2015 Apr;22(2):113-21. doi: 10.3747/co.22.2300.

25.

Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.

Andrei AZ, Hall A, Smith AL, Bascuñana C, Malina A, Connor A, Altinel-Omeroglu G, Huang S, Pelletier J, Huntsman D, Gallinger S, Omeroglu A, Metrakos P, Zogopoulos G.

Cancer Lett. 2015 Aug 1;364(1):8-16. doi: 10.1016/j.canlet.2015.04.003. Epub 2015 Apr 9.

PMID:
25864590
26.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A.

J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.

PMID:
25452445
27.

The prognostic ease and difficulty of invasive breast carcinoma.

Tofigh A, Suderman M, Paquet ER, Livingstone J, Bertos N, Saleh SM, Zhao H, Souleimanova M, Cory S, Lesurf R, Shahalizadeh S, Garcia Lopez N, Riazalhosseini Y, Omeroglu A, Ursini-Siegel J, Park M, Dumeaux V, Hallett M.

Cell Rep. 2014 Oct 9;9(1):129-142. doi: 10.1016/j.celrep.2014.08.073. Epub 2014 Oct 2.

28.

Pilomatricoma of the male breast: sonographic mammographic MRI features with pathologic correlation.

AlSharif S, Meguerditchian A, Omeroglu A, Lamarre P, Altinel G, Mesurolle B.

Clin Imaging. 2015 Mar-Apr;39(2):308-10. doi: 10.1016/j.clinimag.2014.07.005. Epub 2014 Jul 22.

PMID:
25123419
29.

Axillary metastasis from an occult tubal serous carcinoma in a patient with ipsilateral breast carcinoma: a potential diagnostic pitfall.

Atallah C, Altinel G, Fu L, Arseneau J, Omeroglu A.

Case Rep Pathol. 2014;2014:534034. doi: 10.1155/2014/534034. Epub 2014 Jul 9.

30.

Mammographic, sonographic and MR imaging features of invasive micropapillary breast cancer.

Alsharif S, Daghistani R, Kamberoğlu EA, Omeroglu A, Meterissian S, Mesurolle B.

Eur J Radiol. 2014 Aug;83(8):1375-80. doi: 10.1016/j.ejrad.2014.05.003. Epub 2014 May 17.

PMID:
24913934
31.

Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy: frequency, final surgical outcome, and factors associated with underestimation.

Mesurolle B, Perez JC, Azzumea F, Lemercier E, Xie X, Aldis A, Omeroglu A, Meterissian S.

AJR Am J Roentgenol. 2014 Jun;202(6):1389-94. doi: 10.2214/AJR.13.10864.

PMID:
24848840
32.

Infiltrating syringomatous adenoma of the nipple: Sonographic and mammographic features with pathologic correlation.

AlSharif S, Tremblay F, Omeroglu A, Altinel G, Sun S, Mesurolle B.

J Clin Ultrasound. 2014 Sep;42(7):427-9. doi: 10.1002/jcu.22150. Epub 2014 Mar 19.

PMID:
24648330
33.

Post-traumatic neuroma following breast surgery.

Ashkar L, Omeroglu A, Halwani F, Alsharif S, Loutfi A, Mesurolle B.

Breast J. 2013 Nov-Dec;19(6):671-2. doi: 10.1111/tbj.12186. Epub 2013 Sep 19. No abstract available.

PMID:
24102889
34.

Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall.

Salehi AH, Omeroglu G, Kanber Y, Omeroglu A.

Int J Surg Pathol. 2013 Dec;21(6):610-2. doi: 10.1177/1066896913502228. Epub 2013 Sep 10.

PMID:
24021901
35.

Granular cell tumor of the breast detected on MRI screening.

Abbas E, Omeroglu A, Kao E, Altinel G, Fleiszer D, Mesurolle B.

Breast J. 2013 Sep-Oct;19(5):545-7. doi: 10.1111/tbj.12159. Epub 2013 Jul 19. No abstract available.

PMID:
23865836
36.

Extensive renal infarction following percutaneous biopsy of a small renal mass: A case report.

Abourbih S, Aldousari S, Brimo F, Omeroglu A, Kassouf W.

Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E118-20. doi: 10.5489/cuaj.252.

37.

Values of pathological analysis of lost tissue fragments in the vacuum canister during a vacuum-assisted stereotactic biopsy of the breast.

El Khoury M, Mesurolle B, Omeroglu A, Aldis A, Kao E.

Br J Radiol. 2013 May;86(1025):20120270. doi: 10.1259/bjr.20120270. Epub 2013 Mar 21.

38.

Invasive ductal carcinoma of the breast: correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology.

Zheng J, Alsaadi T, Blaichman J, Xie X, Omeroglu A, Meterissian S, Mesurolle B.

AJR Am J Roentgenol. 2013 Jan;200(1):W71-4. doi: 10.2214/AJR.11.7461.

PMID:
23255773
39.

ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.

Mourskaia AA, Amir E, Dong Z, Tiedemann K, Cory S, Omeroglu A, Bertos N, Ouellet V, Clemons M, Scheffer GL, Park M, Hallett M, Komarova SV, Siegel PM.

Breast Cancer Res. 2012 Nov 22;14(6):R149. doi: 10.1186/bcr3361.

40.

Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.

Tabariès S, Dupuy F, Dong Z, Monast A, Annis MG, Spicer J, Ferri LE, Omeroglu A, Basik M, Amir E, Clemons M, Siegel PM.

Mol Cell Biol. 2012 Aug;32(15):2979-91. doi: 10.1128/MCB.00299-12. Epub 2012 May 29.

41.

Flat epithelial atypia of the breast: pathological-radiological correlation.

Solorzano S, Mesurolle B, Omeroglu A, El Khoury M, Kao E, Aldis A, Meterissian S.

AJR Am J Roentgenol. 2011 Sep;197(3):740-6. doi: 10.2214/AJR.10.5265.

PMID:
21862819
42.

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.

Tabariès S, Dong Z, Annis MG, Omeroglu A, Pepin F, Ouellet V, Russo C, Hassanain M, Metrakos P, Diaz Z, Basik M, Bertos N, Park M, Guettier C, Adam R, Hallett M, Siegel PM.

Oncogene. 2011 Mar 17;30(11):1318-28. doi: 10.1038/onc.2010.518. Epub 2010 Nov 15.

PMID:
21076473
43.

Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.

Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12903-8. doi: 10.1073/pnas.0810402106. Epub 2009 Jul 17.

44.

Breast tumor resembling the tall cell variant of papillary thyroid carcinoma.

Chang SY, Fleiszer DM, Mesurolle B, El Khoury M, Omeroglu A.

Breast J. 2009 Sep-Oct;15(5):531-5. doi: 10.1111/j.1524-4741.2009.00773.x. Epub 2009 Jul 5.

PMID:
19594763
45.

Obstructive uropathy associated with primary ureteral endometrioma: case report and review of the literature.

Feifer A, El-Din MA, Omeroglu A, Anidjar M.

Can Urol Assoc J. 2009 Jun;3(3):E10-E13.

46.

Stromal gene expression predicts clinical outcome in breast cancer.

Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M.

Nat Med. 2008 May;14(5):518-27. doi: 10.1038/nm1764. Epub 2008 Apr 27.

PMID:
18438415
47.

Surgical strategies for severe calcification of the aorta (porcelain aorta) in two patients with homozygous familial hypercholesterolemia.

Grenon SM, Lachapelle K, Marcil M, Omeroglu A, Genest J, de Varennes B.

Can J Cardiol. 2007 Dec;23(14):1159-61.

48.

Analysis of PALB2/FANCN-associated breast cancer families.

Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD.

Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6788-93. Epub 2007 Apr 9.

49.
50.

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors.

Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M.

Breast Cancer Res. 2006;8(5):R58.

Supplemental Content

Loading ...
Support Center